Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIUMPHANT-MS: Amantadine, Modafinil, and Methylphenidate for MS Fatigue
NCT03185065Phase 3Completed
- Sponsor
- Johns Hopkins University
- Start
- Oct 2017
- Primary completion
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of amantadine, modafinil, methylphenidate hydrochloride extended-release chewable tablet in fatigue, sponsored by Johns Hopkins University. Started Oct 2017; status: completed.
02
Drugs
amantadinemodafinilmethylphenidate hydrochloride extended-release chewable tablet
03
Conditions
fatigue
Beyond the preview
Go deeper on NCT03185065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03185065.